Showing 1,461 - 1,480 results of 16,418 for search '"Therapy"', query time: 0.09s Refine Results
  1. 1461
  2. 1462
  3. 1463
  4. 1464
  5. 1465

    Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori by Lingyun Zhang, Yu Lan, Qi Wang, Yuexia Zhang, Xiaobei Si

    Published 2019-01-01
    “…A 3 to 5-day follow-up was adopted to evaluate the safety and compliance of medications after medicine administration. 13C-urea breath test was performed to confirm the eradication of H. pylori 4-12 weeks after therapy. Results. No significant differences were observed at baseline data among the three groups (p>0.05). …”
    Get full text
    Article
  6. 1466

    Strategies for preventing and managing osteoporosis in elderly breast cancer patients undergoing aromatase inhibitor therapy by Andi Tian, Chunyu Zhang

    Published 2025-01-01
    “…For patients with estrogen receptor-positive breast cancer, endocrine therapy targeting estrogen pathways remains a cornerstone of postoperative treatment. …”
    Get full text
    Article
  7. 1467

    Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis by Manning Li, Ying Xie

    Published 2025-02-01
    “…In recent years, there has been controversy regarding whether adding Saccharomyces boulardii (S. boulardii) to traditional therapies is beneficial for eradicating H. pylori.AimTo evaluate the efficacy and safety of S. boulardii as an adjuvant therapy for the eradication of H. pylori.MethodsWe systematically searched the PubMed and Web of Science databases from January 2002 to January 2023. …”
    Get full text
    Article
  8. 1468
  9. 1469

    Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome by Maha A. Badawi, Linda M. Vickars, Jocelyn M. Chase, Heather A. Leitch

    Published 2010-01-01
    “…Iron chelation therapy is often used to treat iron overload in patients requiring transfusion of red blood cells (RBC). …”
    Get full text
    Article
  10. 1470

    Efficacy of rituximab as second-line therapy for autoimmune encephalitis: A systematic review and meta-analysis by Lin-ming Zhang, Xuan-lin Xing, Bing-ran Zhang, Qiu-juan Zhang, Yan-lin Zhu, Shu-ji Gao, Ming-wei Liu

    Published 2025-01-01
    “…Background: Approximately 20%–50 % of individuals with autoimmune encephalitis (AE) demonstrate suboptimal responses to first-line therapies, leading to persistent neurological deficits and the need for second-line interventions. …”
    Get full text
    Article
  11. 1471
  12. 1472

    Towards faster plan adaptation for proton arc therapy using initial treatment plan information by Benjamin Roberfroid, Margerie Huet-Dastarac, Elena Borderías-Villarroel, Rodin Koffeing, John A. Lee, Ana M. Barragán-Montero, Edmond Sterpin

    Published 2025-01-01
    “…Background and Purpose: Proton arc therapy (PAT) is an emerging modality delivering continuously rotating proton beams. …”
    Get full text
    Article
  13. 1473
  14. 1474

    Nonsurgical Outpatient Therapies for the Management of Female Stress Urinary Incontinence: Long-Term Effectiveness and Durability by G. Willy Davila

    Published 2011-01-01
    “…Conclusions. Conservative therapy is an appropriate initial approach for female SUI, but if therapy fails, radiofrequency collagen denaturation or bulking agents may be an attractive intermediate management step or alternative to surgery.…”
    Get full text
    Article
  15. 1475

    Surgical Site Infections Complicating the Use of Negative Pressure Wound Therapy in Renal Transplant Recipients by Susanna Lam, Ngee-Soon Lau, Jerome Martin Laurence, Deborah Jean Verran

    Published 2019-01-01
    “…Surgical site infections (SSI) of the abdominal wall in renal transplant recipients can on occasion require management with negative pressure wound therapy (NPWT). This is often successful, with a low risk of further complications. …”
    Get full text
    Article
  16. 1476
  17. 1477
  18. 1478

    Effects of Jianpi therapy for cancer-related fatigue:a meta-analysis of randomized controlled trials by Jiaxing Dai, Jiaxing Dai, Huili Shui, Huili Shui, Huili Shui, Yuan Wu, Huanghui Zhang, Huanghui Zhang, Yuanyin Li, Yuanyin Li, Shaowang Zhang, Shaowang Zhang, Bing Yang, Bing Yang, Bing Yang, Dongxin Tang, Dongxin Tang, Dongxin Tang

    Published 2025-01-01
    “…This research systematically evaluates the effectiveness of Jianpi therapy in reducing fatigue in cancer patients through a meta-analytic review.MethodsAn exhaustive search was performed within PubMed, Embase, Web of Science, Cochrane Library, SinoMed, Wanfang Data, China Science and Technology Journal Database, and China National Knowledge Infrastructure (CNKI) for randomized controlled trials concerning the application of Jianpi therapy to address CRF. …”
    Get full text
    Article
  19. 1479

    Effect of Periodontal Therapy on Crevicular Fluid Interleukin-6 and Interleukin-8 Levels in Chronic Periodontitis by Paschalina Goutoudi, Evdoxia Diza, Malamatenia Arvanitidou

    Published 2012-01-01
    “…The aim of this study was to analyse the levels of interleukin-6 (IL-6) and interleukin-8 (IL-8) in gingival crevicular fluid (GCF) of patients with chronic periodontitis prior to and following surgical and/or nonsurgical periodontal therapy for a period of 32 weeks. Methods. GCF samples were obtained from 24 nondiseased and 72 diseased sites of 12 periodontal patients prior to as well as at 6, 16, and 32 weeks following non-surgical and surgical periodontal therapy. …”
    Get full text
    Article
  20. 1480